| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-06 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-06 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.24 |
9e-06 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |